Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy. - Wikidata - awgldk - TriplyDB

Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.

Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.

http://www.wikidata.org/entity/Q41997560

about

Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study Gastrointestinal effects of aspirin.Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.Influence of duodenogastric reflux in the gastric mucosa histological changes of rats infected with Helicobacter pylori.Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.

P2860

Q26864640-8A037706-C545-4AB8-92A7-7830D785AA44 Q34445624-1988F780-D897-4702-B823-DD1D63117C53 Q35683846-09217223-23C3-4DAE-BCA9-E40552D08E05 Q36412892-39EC272C-7B63-4FE8-8F14-9E49E70E1874 Q37885723-F005E720-43B7-4BBF-8FC1-3C9373AA9894 Q38809179-4D556D19-D872-4FED-A712-928AA159AD1E Q40524995-9E84B08D-DDF2-4F1D-9429-0044F17413A5 Q42219817-EA7D3D4D-9F6F-4CE9-9A13-DA62D1632C24 Q43216541-558FAFB8-D573-4872-80BB-79FC8FB91601 Q55071130-F61398E9-10E3-4913-A08D-406B9D43123E

P2860

Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.

http://www.wikidata.org/entity/Q41997560

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Comparative study of therapeut ...... ng continuous aspirin therapy.

@en

type

label

Comparative study of therapeut ...... ng continuous aspirin therapy.

@en

prefLabel

Comparative study of therapeut ...... ng continuous aspirin therapy.

@en

P1433

Q41997560-9379AD85-CE7A-4243-ADC3-CBB92637F827

P1476

Q41997560-25E3C74C-F692-45FF-9049-9CDF28B45A64

P2093

Q41997560-40B30388-E585-4250-B44E-4FF7F821A271

Q41997560-CA0C4197-2213-4A3D-8576-E7FC896DDE92

P2860

Q41997560-0AC0D548-757A-40F5-98C4-F41271258054

Q41997560-1723F074-B457-4E48-8B63-52BCC7FC3EE4

Q41997560-4541EE4E-5E73-4399-84D1-F1548AAFE94B

Q41997560-4E6CB790-3A0A-4F96-BE30-D5E063F7E4D0

Q41997560-5C582B4E-C54B-439D-8256-2008FE05476A

Q41997560-93E9D611-74FA-480A-96B0-C12081720C20

Q41997560-94F8A2DB-D119-47A4-A677-57D6DF0429D9

Q41997560-9601D986-690E-4711-A19C-13542A032080

Q41997560-A2E2A722-FADB-4864-B285-C313F7932A51

Q41997560-A91BEFEF-1794-4502-B66D-6047B6698C09

P304

Q41997560-D4AA5E79-2421-4432-967A-6116BA3DE7AC

P31

Q41997560-797712D8-E6CE-4E67-BEBB-2CDEA8418771

P356

Q41997560-989FEC2B-0EE7-4DDF-AF47-C22052EB83EF

P407

Q41997560-D37498AC-1AE0-4307-B4E1-A9EDE4746069

P433

Q41997560-91015094-1BD8-40BF-A1DA-104F78E87F12

P478

Q41997560-1CC4B622-8116-4E88-9A84-AB8D5DBD9DB5

P577

Q41997560-0B806F0B-7086-41C4-BEC0-BCD9776506D4

P698

Q41997560-D373D813-95E5-4CCE-B62C-AAAFAD34F58F

P932

Q41997560-AAEBDE99-5D8B-44FE-97BA-87DF4C538930

P356

WJG.V16.I42.5342

P1433

World Journal of Gastroenterology

P1476

Comparative study of therapeut ...... ng continuous aspirin therapy.

@en

P2093

Hiroaki Nema

http://www.w3.org/2001/XMLSchema#string

Mototsugu Kato

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke

Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study

Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.

Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.

Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.

P304

5342-5346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I42.5342

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21072898

http://www.w3.org/2001/XMLSchema#string

P932

2980684

http://www.w3.org/2001/XMLSchema#string